FY2025 EPS Estimates for TSHA Increased by Cantor Fitzgerald
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 EPS estimates for shares of Taysha Gene Therapies in a note issued to investors on Thursday, June 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings of ($0.33) per share for the year, […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 EPS estimates for shares of Taysha Gene Therapies in a note issued to investors on Thursday, June 12th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings of ($0.33) per share for the year, […]
